Some links on our site may earn us a commission at no extra cost to you. Learn more.
This article is for general education only. It is not medical advice, and it cannot diagnose your hearing or tell you what device is right for your ears. Hearing loss has many causes, some of which need a doctor’s attention, not a gadget. If you have sudden, one-sided, or painful hearing loss, ringing that won’t stop, or dizziness along with your hearing changes, see a physician or audiologist before buying anything.
The short version: “OTC hearing aid” is a specific, FDA-regulated device category created by a 2022 rule — it is not the same thing as a pair of earbuds with a “hearing enhancement” feature, and neither one is the same as a prescription hearing aid fitted by an audiologist. If you have mild-to-moderate, self-perceived hearing loss and you’re an adult, OTC hearing aids are a legitimate, regulated place to start. If your hearing loss is more severe, sudden, one-sided, or you’re not sure how bad it is, that’s a prescription-and-audiologist conversation, not a shopping decision.
At a Glance: Which Tier Is Actually Right for You?
- Best starting point for most first-time OTC buyers: a self-fitting OTC hearing aid with audiologist-designed lineage and app-guided fitting, such as Jabra Enhance Select or Sony’s CRE line.
- Best if you already own compatible hardware: the Hearing Aid feature built into AirPods Pro 2 and AirPods Pro 3, which is itself FDA-authorized as OTC hearing aid software, not a gimmick add-on.
- Best for casual, situational amplification (not a medical need): a personal sound amplification product (PSAP) or “hearing enhancement” earbud, for people with normal hearing who just want an edge in noisy rooms.
- Skip for now: Eargo and Lexie. Their parent company, LXE Hearing, began winding down U.S. operations in mid-2026, and long-term app, warranty, and parts support beyond September 15, 2026 is unconfirmed as of publication.
- See a professional first, don’t shop yet, if: your hearing loss came on suddenly, affects one ear more than the other, or comes with pain, drainage, or dizziness.
What’s the Difference Between OTC Hearing Aids, Prescription Hearing Aids, and Hearing-Enhancement Earbuds?
The single most useful thing to understand before you spend a dollar is that these are three different regulatory categories, not three price tiers of the same product. The table below is our own comparison, built from the FDA’s OTC hearing aid final rule and current device labeling, not a manufacturer’s marketing page.
| Tier | FDA Status | Who It’s Actually For | Who Fits/Programs It | What It Can Legally Claim |
|---|---|---|---|---|
| OTC hearing aid | FDA-regulated medical device category, established by the OTC hearing aid final rule effective October 17, 2022 | Adults 18+ with self-perceived mild-to-moderate hearing loss | You, using in-app hearing tests and self-fitting tools | May be marketed and sold as a hearing aid, within labeled output limits |
| Prescription hearing aid | FDA-regulated medical device, sold only through a licensed hearing care provider | Any age, any severity, including severe or profound hearing loss | A licensed audiologist or hearing instrument specialist, programmed to your audiogram | May be marketed as a hearing aid for any degree of hearing loss |
| Hearing-enhancement earbuds / PSAPs | Not an FDA medical device category at all | People with normal hearing who want situational amplification (restaurants, TV, birdwatching) | No professional fitting; consumer app EQ only | Cannot legally be marketed to treat hearing loss or as a hearing aid substitute |
Per the FDA’s own guidance, the agency “regulates” this device category rather than “approving” individual OTC hearing aids the way it might approve a drug — that distinction matters because you’ll see marketing copy that blurs it constantly.
What Does “FDA-Regulated” Actually Mean for OTC Hearing Aids?
The FDA’s OTC hearing aid rule took effect October 17, 2022, following a final rule published in the Federal Register that August. It created a brand-new device category available to consumers “without the supervision, involvement, or prescription of a licensed health care professional,” according to the FDA’s consumer guidance on the rule. That’s the whole point of the category: it removes the requirement for an audiologist visit, but it does not remove FDA oversight of the device itself.
Two things follow from that. First, OTC hearing aids still have to meet FDA-set safety and output limits, and their packaging has to carry specific labeling, including a cap on how loud they can get. Second, and this is the part sellers gloss over most often, the category is explicitly limited to adults with self-perceived mild-to-moderate hearing loss. There’s no clinical gatekeeping at the point of sale, which is the whole appeal, but it also means the device isn’t designed or labeled for anything beyond that range. If you buy one for a level of hearing loss it wasn’t built for, it may simply underperform rather than help.
Who Should Actually Consider an OTC Hearing Aid?
OTC hearing aids make the most sense for adults who suspect a mild-to-moderate hearing change (trouble in restaurants, needing the TV louder, missing parts of conversations in groups) and who haven’t yet had that confirmed by a professional but want to try amplification. They’re a reasonable first step, not a substitute for care if things don’t improve.
Pros:
- No audiologist visit or prescription required to purchase
- Meaningfully lower cost than most prescription devices
- Many models now include in-app hearing screening tools to help set starting levels
- Some, like Jabra Enhance Select, bundle a period of remote (telehealth) professional support into the purchase price
Cons / honest dealbreakers:
- Not built for, and not labeled for, severe or profound hearing loss
- Self-fitting means you’re relying on an in-app test, not a sound-booth audiogram
- Battery/electronics lifespan is shorter than many people expect from a “hearing aid” purchase
- Some direct-to-consumer OTC brands have shown they can wind down support with little warning (see below)
What Are the Best-Regarded OTC Hearing Aids Right Now?
We’re separating this into what’s currently worth prioritizing and what’s currently a caution flag, because the OTC hearing aid market has moved fast since 2022 and not every early entrant is still stable.
Must-have tier — devices with clinical-audiology lineage and active manufacturer support:
- Jabra Enhance Select (300, 700, and the entry 50R) — priced from roughly $1,195 to around $1,995 per pair depending on tier, with the app free and no separate subscription; the purchase price bundles about three years of remote telehealth support.
- Sony CRE-C10 / CRE-E10 — Sony’s OTC line, developed with hearing aid maker WS Audiology; the CRE-C10 runs about $998 and uses a disposable-battery design rated for roughly 70 hours between changes, while the CRE-E10 adds Bluetooth audio streaming.
Nice-to-have / budget tier — usable, but with fewer clinical guardrails:
- Audien Atom Pro 2 — around $250–$290, no app required, preset amplification modes rather than a guided self-fit. Fine as a low-commitment entry point; don’t expect audiologist-grade fine-tuning.
- Elehear Delight / Beyond Pro — roughly $299–$599 depending on model and promotions, earbud-style OTC devices with app control. Newer, direct-to-consumer brand with a shorter public track record than Jabra or Sony.
Caution — brands in transition, hold off buying new:
- Eargo and Lexie (Powered by Bose) — both are owned by LXE Hearing, which announced a U.S. wind-down of operations in mid-2026. Existing devices and apps reportedly continue to function for now, but the company has not finalized long-term plans for app support, warranty claims, or replacement parts past September 15, 2026. That’s not a reason to panic if you already own one, but it’s a real reason not to buy new right now until the transition is resolved.
What About AirPods Pro and Other “Hearing Aid Mode” Earbuds?
This is where the category gets genuinely confusing, so it’s worth being precise. Apple’s Hearing Aid feature, available on compatible AirPods Pro 2 and AirPods Pro 3 models running the required iOS version, was authorized by the FDA as an over-the-counter hearing aid — the FDA’s own announcement described it as the first OTC hearing aid software of its kind. Once you run the in-app hearing test and turn the feature on, that specific mode is functioning as a regulated OTC hearing aid, intended for adults 18 and older with perceived mild-to-moderate hearing loss, same as a dedicated OTC device.
That’s different from the everyday “Conversation Boost,” Transparency mode, or generic “hearing enhancement” features found on plenty of other consumer earbuds, including some non-Apple models and standalone products like Sennheiser’s Conversation Clear Plus (about $850). Those are personal sound amplification products, not regulated hearing aids of any kind. They can make speech easier to pick out in a noisy room, but by law they cannot be marketed to treat hearing loss, and nothing requires them to meet the FDA’s OTC hearing aid output and safety limits. That’s not automatically a problem for someone with normal hearing who wants situational help, but it’s the wrong tool if you suspect an actual hearing loss.
When Do You Actually Need a Prescription Hearing Aid Instead?
Prescription hearing aids remain the only category that legally covers every degree of hearing loss and every age, including children, and they’re the right call whenever OTC eligibility doesn’t fit: severe or profound loss, sudden or one-sided hearing changes, or hearing loss in a minor. A licensed audiologist programs the device to your specific audiogram rather than a self-guided in-app test, and ongoing adjustments are part of the relationship, not a one-time purchase.
That professional involvement is also most of why prescription devices cost more. According to hearing aid pricing data compiled by HearingTracker in 2026, the average price paid for a pair of prescription hearing aids across all purchase channels was about $2,694, with private-pay clinic pricing running roughly $2,150 for entry-level technology up to about $5,225 for top-tier technology per pair. By brand, HearingTracker’s data put private-pay averages at roughly $4,185 for Widex, $4,132 for Phonak, $3,893 for Starkey, $3,840 for Oticon, $3,327 for ReSound, and $3,256 for Signia. Membership-warehouse pricing, such as Costco’s audiology program, has averaged notably lower, around $1,674 per pair, for comparable technology.
How Much Do These Three Tiers Actually Cost Over Time?
Sticker price alone is misleading here because the tiers don’t wear out on the same schedule and don’t all carry the same ongoing costs. We built the table below ourselves from the verified price points above, using each tier’s typical replacement cycle to calculate an approximate cost per year of ownership. Treat the “per year” column as a rough planning number, not a quote.
| Tier | Typical Device Cost (per pair) | App / Subscription | Typical Replacement Cycle | Our Approx. Cost per Year |
|---|---|---|---|---|
| OTC hearing aid | ~$250–$2,000 (budget to Jabra/Sony tier) | Usually none; some bundle telehealth into the purchase price | ~3–4 years | Roughly $85–$500/year, tier-dependent |
| Prescription hearing aid | ~$2,150–$5,225 (private pay, per HearingTracker’s 2026 data) | None beyond purchase; fitting/adjustments typically bundled | ~5–6 years | Roughly $390–$950/year |
| Hearing-enhancement earbuds / PSAPs | ~$150–$850 | Usually none | ~2–3 years (standard consumer earbud lifespan) | Roughly $60–$400/year |
The pattern worth noticing: prescription devices cost the most upfront but last the longest and bundle the most professional service, so their effective annual cost isn’t as far from a premium OTC device as the sticker prices suggest. Budget OTC and PSAP-style hearables are cheapest per year, but that’s partly because they’re built and replaced on a consumer-electronics timeline, not a medical-device one.
What Are the Real Dealbreakers to Know Before Buying?
A few honest cautions that don’t show up on product pages:
- “FDA approved” is the wrong phrase. No hearing aid, OTC or prescription, is “FDA approved” in the way a drug is. OTC hearing aids are FDA-regulated under the 2022 rule; the correct word is regulated, cleared, or authorized, depending on the specific product.
- Self-fitting isn’t the same as a real hearing test. An in-app tone test is a starting point, not a diagnosis. If your hearing hasn’t changed the way you expect after a few weeks of consistent OTC use, that’s a sign to see a professional, not to keep app-tweaking.
- Company stability matters more than most buyers assume. The LXE Hearing situation with Eargo and Lexie is a live example: a hearing aid you rely on daily is only as good as the company that keeps its app and firmware alive.
- A “hearing enhancement” claim on an earbud box is not a medical claim. If a product avoids the words “hearing aid” and “hearing loss” entirely, that’s often because it legally can’t make those claims — read the fine print, not just the headline feature list.
How We Researched This Guide
We built this guide from the FDA’s published OTC hearing aid final rule and consumer guidance, current manufacturer pricing and specification pages, and independent hearing-industry reporting and pricing surveys, cross-checked against verified long-term owner feedback and reliability patterns rather than a single source’s marketing claims. We did not conduct hands-on lab testing of these devices for this guide; where we describe performance or reliability patterns, that reflects a consensus read across professional and owner sources, not our own clinical measurement. Regulatory status and pricing were confirmed as current as of publication, and both change; when a specific brand’s situation was actively unfolding (as with the LXE Hearing wind-down), we noted that explicitly rather than treating it as settled. Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying. For more on how we approach reviews sitewide, see our editorial standards.
Published August 8, 2026. Last updated August 8, 2026.
Frequently Asked Questions
Are OTC hearing aids FDA approved?
Not in the way that phrase usually implies. The FDA doesn’t “approve” hearing aids the way it approves a drug; instead, it regulates OTC hearing aids as a specific device category under a rule that took effect October 17, 2022. Individual products still have to meet the FDA’s safety, output, and labeling requirements for that category.
Can I use AirPods Pro as a hearing aid?
Only the dedicated Hearing Aid feature on compatible AirPods Pro 2 and AirPods Pro 3 models counts as an actual OTC hearing aid — it was authorized by the FDA as OTC hearing aid software. Other features like Conversation Boost or Transparency mode on AirPods or other earbuds are general hearing-enhancement features, not regulated hearing aids.
What’s the difference between a PSAP and an OTC hearing aid?
A personal sound amplification product (PSAP) is built for people with normal hearing who want situational amplification and is not an FDA medical device category. An OTC hearing aid is a regulated medical device specifically intended for adults with mild-to-moderate hearing loss, and by law it can be marketed that way; a PSAP cannot.
When do I need a prescription hearing aid instead of an OTC one?
If your hearing loss is severe or profound, sudden, one-sided, affects a child, or hasn’t been evaluated by a professional at all, a prescription hearing aid fitted by a licensed audiologist is the appropriate route, not an OTC purchase.
How long do OTC hearing aids and hearables actually last?
Most OTC hearing aids are built for roughly a 3–4 year usable life before battery and hardware wear make replacement worthwhile, while prescription devices are typically kept closer to 5–6 years. Earbud-style hearables with hearing-enhancement features generally follow a normal consumer-electronics replacement cycle of about 2–3 years.
Are Eargo and Lexie hearing aids safe to buy right now?
We’d hold off. Their parent company, LXE Hearing, began winding down U.S. operations in mid-2026, and as of publication it hasn’t finalized long-term plans for app support, warranties, or replacement parts beyond September 15, 2026. Existing owners’ devices reportedly still work, but new buyers should wait for that transition to resolve.
Related Reading on FindsWeTrust
Shopping for other wearable tech this year? See our Phones & Wearables coverage, including our Apple Watch Series 11 review (which covers its own FDA-cleared health alert feature), our Sony WH-1000XM5 review, and our roundup of audio, video, and gaming gear for 2026.
